ARCHIVES

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

Wong To Head MSKCC Colorectal Service; How You Know When To Stop Advising NCI.

June 29, 2001

High Vitamin E Consumption Can Lower Liver Cancer Risks

July 27, 2012

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

Cigarette Smoking increases Among Youth, Annual Report Finds

January 12, 1996

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012